139 related articles for article (PubMed ID: 35188016)
1. Development of herpetrione nanosuspensions stabilized by glycyrrhizin for enhancing bioavailability and synergistic hepatoprotective effect.
Hang L; Hu F; Shen C; Shen B; Zhu W; Yuan H
Drug Dev Ind Pharm; 2021 Oct; 47(10):1664-1673. PubMed ID: 35188016
[TBL] [Abstract][Full Text] [Related]
2. Enhanced intestinal absorption activity and hepatoprotective effect of herpetrione via preparation of nanosuspensions using pH-dependent dissolving-precipitating/homogenization process.
Shen B; Jin S; Lv Q; Jin S; Yu C; Yue P; Han J; Yuan H
J Pharm Pharmacol; 2013 Sep; 65(9):1382-92. PubMed ID: 23927477
[TBL] [Abstract][Full Text] [Related]
3. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation.
Rui TQ; Zhang L; Qiao HZ; Huang P; Qian S; Li JS; Chen ZP; Fu TM; Di LQ; Cai B
J Pharm Sci; 2016 Jan; 105(1):242-9. PubMed ID: 26852855
[TBL] [Abstract][Full Text] [Related]
6. Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects.
Zhong Y; Hang L; Wang F; Shen B; Shen C; Xue Y; Jia H; Wang L; Yuan H
J Microencapsul; 2023 Dec; 40(8):587-598. PubMed ID: 37733492
[TBL] [Abstract][Full Text] [Related]
7. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.
Shen G; Cheng L; Wang LQ; Zhang LH; Shen BD; Liao WB; Li JJ; Zheng J; Xu R; Yuan HL
Chin J Nat Med; 2016 Oct; 14(10):757-768. PubMed ID: 28236405
[TBL] [Abstract][Full Text] [Related]
8. Improved stability and oral bioavailability of Ganneng dropping pills following transforming lignans of herpetospermum caudigerum into nanosuspensions.
Li JJ; Cheng L; Shen G; Qiu L; Shen CY; Zheng J; Xu R; Yuan HL
Chin J Nat Med; 2018 Jan; 16(1):70-80. PubMed ID: 29425592
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
Wang Y; Han X; Wang J; Wang Y
Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
[TBL] [Abstract][Full Text] [Related]
11. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of Nanosuspensions to Improve the Oral Bioavailability of Total Flavones from Hippophae rhamnoides L. and their Comparison with an Inclusion Complex.
Tian R; Wang H; Xiao Y; Hu P; Du R; Shi X; Wang Z; Xie Y
AAPS PharmSciTech; 2020 Sep; 21(7):249. PubMed ID: 32875458
[TBL] [Abstract][Full Text] [Related]
13. Ritonavir nanosuspensions prepared by microfluidization with enhanced solubility and desirable immunological properties.
Karakucuk A; Canpinar H; Celebi N
Pharm Dev Technol; 2022 Dec; 27(10):1027-1037. PubMed ID: 36343117
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions.
Sun W; Gao J; Fan R; Zhang T; Tian Y; Wang Z; Zhang H; Zheng A
Int J Nanomedicine; 2022; 17():1741-1755. PubMed ID: 35469173
[TBL] [Abstract][Full Text] [Related]
15. Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on
Zhu Y; Hu F; Shen C; Shen B; Yuan H
Pharm Dev Technol; 2024 Jun; ():1-8. PubMed ID: 38808380
[TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of a novel oral fast dissolving film containing drug nanoparticles by Box-Behnken design-response surface methodology.
Shen C; Shen B; Xu H; Bai J; Dai L; Lv Q; Han J; Yuan H
Drug Dev Ind Pharm; 2014 May; 40(5):649-56. PubMed ID: 24506458
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
Allam AN; Hamdallah SI; Abdallah OY
Int J Nanomedicine; 2017; 12():4733-4745. PubMed ID: 28740381
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y
Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183
[TBL] [Abstract][Full Text] [Related]
20. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.
Yang D; Li R; Zhang F; Qin L; Peng F; Jiang S; He H; Lu X; Zhang P
Drug Deliv Transl Res; 2020 Feb; 10(1):192-201. PubMed ID: 31482518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
